Worldwide experience with biosimilar development

mAbs

Volumn 3, Issue 2, 2011, Pages 209-217

  McCamish, Mark ^a   Woollett, Gillian ^b  

^a Sandoz Pharma Ltd   (Switzerland)

^b LLP   (United States)

Author keywords

Biosimilars; Monoclonal antibodies (mABs); Recombinant biopharmaceuticals

Indexed keywords

BIOLOGICAL FACTOR; ENOXAPARIN; MONOCLONAL ANTIBODY; NEW DRUG; BIOLOGICAL PRODUCT;

DRUG LEGISLATION; EUROPE; FOOD AND DRUG ADMINISTRATION; PRACTICE GUIDELINE; REVIEW; UNITED STATES; ARTICLE; DRUG APPROVAL; ECONOMICS; HUMAN; LEGAL ASPECT; PATENT; PHARMACOKINETICS; STANDARD;

ANTIBODIES, MONOCLONAL; BIOLOGICAL PRODUCTS; DRUG APPROVAL; EUROPE; HUMANS; PATENTS AS TOPIC; THERAPEUTIC EQUIVALENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79952744875     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.3.2.15005     Document Type: Review

References (25)

1. Pharmaceutical Research and Manufacturers of America. Biotechnology Medicines in Development Report 2008; www.phrma.org/sites/phrma.org/files/ attachments/Biotech%202008.pdf
2. So AD, Katz SL. Biologics Boondoggle New York Times, March 8, 2010.
3. DIRECTIVE 2004/27/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2004:136:0034:0057:EN:PDF
4. European Public Assessment Report EMEA/ H/C/607. Omnitrope (somatropin). www.ema.europa. eu/docs /en-GB/document-library/EPAR---Summa r y-for-t he-publ ic /human/ 000607/WC500043689.pdf
5. Demonstration of Comparability of Human Biological Products, Including Therapeutic Biotechnologyderived Products, Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER) April 1996. www.fda.gov/Drugs/GuidanceCompl ianceRegulatoryInformat ion/Guidances/ucm122879. htm
6. Casadevall N. Immune-response and adverse reactions: PRCA case example. http://www.ema.europa.eu/docs/en-GB/document-library/Presentation/2009/11/ WC500011064.pdf
7. Usdin S. Myozyme's zig zags. BioCentury 2008; 16:1-6.
8. EU Guideline on Comparability of Medicinal Products containing Biotechnology-derived Proteins as Active Substances: Quality issues (CPMP December 2003). www.emea.europa.eu/pdfs/human/bwp/320700en.pdf
9. ICH Q5E: Comparability of Biotechnological/ Biological Products Subject to Changes in Their Manufacturing Process. EU: Adopted by CMPM, December 1, 2004, CPMP/ICH/5721/03, date for coming into operation: June 2005; MHLW: Adopted 26 April 2005, PFSB/ELD Notification No. 0426001; FDA: Published in the Federal Register, Vol. 70, No. 125, June 30, 2005; 37861-2. www.ich.org/fileadmin/ Public-Web-Site/ICH-Products/Guidelines/Quality/Q5E/Step4/Q5E-Guideline.pdf
10. DIRECTIVE 2004/27/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2004:136:0034:0057:EN:PDF
11. Senate HELP Full Committee Hearing "Follow-On Biologics" March 8, 2007; http://help.senate.gov/hearings/hearing/?id=0d7fdce8-b5cd-5a56-8930- 31dfb58e7c11.
12. FDA Public Hearing on Approval Pathway for Biosimilar and Interchangeable Biological Products, 11/3/2010 Transcript Document ID: FDA-2010-N-0477-012. www.regulations.gov/search/Regs/home.html#documentDetail?R=0900006480bafe46.
13. Federal register notice Food and Drug Administration [Docket No. FDA-2010-N-0477] Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments. http: //edocket.access.gpo.gov/ 2010/pdf /2010-24853.pdf
14. Biologics Price Competition and Innovation Act (BPCIA) provisions of the Patient Protection and Affordable Care Act (PPACA). http://frwebgate. access.gpo.gov/cgi-bin/getdoc.cgi?dbname=111-cong-bills&docid=f:h3590enr. txt.pdf
15. Schellekens H. Biosimilar epoetins: How similar are they? Eur J Hosp Pharm 2004; 10:243-7.
16. Brockmeyer C, Seidl A. Binocrit: assessment of quality, safety and efficacy of biopharmaceuticals. Eur J Hosp Pharm Prac 2009; 15:34-40.
17. European Generics Medicines Association. EGA Conference Highlights: 6th European Generics Medicines Association Biosimilars Symposium 2008. www.egagenerics.com/doc/ega-high-lights-2008-02.pdf
18. Novartis submission to FDA-2010-N-0477 docket on Notice: Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing. www.regulations.gov/#!documentDetail;D=FDA-2010-N-0477-064.1.
19. Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States. Statement of Janet Woodcock MD, Deputy Commissioner, Chief Medical Officer, Food and Drug Administration before the Subcommittee on Health, House Committee on Energy and Commerce May 2, 2007. www.fda.gov/NewsEvents/ Testimony/ucm154017.htm
20. Follow-on Protein Products. Statement of Janet Woodcock MD, Deputy Commissioner, Chief Medical Officer Food and Drug Administration before the House Committee on Oversight and Government Reform, March 26, 2007. www.fda.gov/NewsEvents/Testimony/ucm154070.htm
21. FDA Guidance for Industry. Q8, Q9 and Q10 Questions and Answers. www.fda.gov/downloads/Drugs/GuidanceCompl ianceRegulatoryInformation/Guidances/ UCM210822.pdf
22. FDA response to the Citizen petitions of Pfizer, BIO and Genentech. Re: Dockets Nos. 2004P-0231/CP1 and SUP1, 2003P-0176/CP1 and EMC1, 2004P-0171/CP1 and 2004N-0355. www.fda.gov/ohrms/dockets/dockets/04P0231/04P-0231-pdn0001.pdf
23. WHO Expert Committee on Biological Standardization, Geneva, 19 to 23 October 2009. Guidelines on evaluation of similar biotherapeutic products (SBPs). www.who.int/biologicals/areas/biological-therapeutics/BIOTHERAPEUTICS- FOR-WEB-22APRIL2010.pdf
24. th European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland. mAbs 2011; 3; 111-34.
25. European Medicines Agency. Biosimilar guidelines. www.ema.europa.eu/ema/ index.jsp?curl=pages/regulation/general/general-content-000408.jsp&murl= menus/regulations/regulations.jsp&mid=WC0b01ac058002958c